{"id":"https://openalex.org/W4362492907","doi":"https://doi.org/10.1158/1535-7163.c.6538327.v1","title":"Data from Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death","display_name":"Data from Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362492907","doi":"https://doi.org/10.1158/1535-7163.c.6538327.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6538327.v1","doi":"https://doi.org/10.1158/1535-7163.c.6538327.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6538327.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6538327.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041093265","display_name":"Xiaoou Xu","orcid":"https://orcid.org/0009-0002-5589-557X","observed_orcids":["https://orcid.org/0009-0002-5589-557X"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]},{"id":"https://openalex.org/I4405287106","display_name":"Institute of Natural Medicine, University of Toyama","ror":"https://ror.org/0449t5597","country_code":"JP","type":"facility","lineage":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Xiaoou Xu","raw_affiliation_strings":["Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan","institution_ids":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041668354","display_name":"Shizuka Eshima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]},{"id":"https://openalex.org/I4405287106","display_name":"Institute of Natural Medicine, University of Toyama","ror":"https://ror.org/0449t5597","country_code":"JP","type":"facility","lineage":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shizuka Eshima","raw_affiliation_strings":["Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan","institution_ids":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113931278","display_name":"Shinichiro Kato","orcid":"https://orcid.org/0009-0006-5796-024X","observed_orcids":["https://orcid.org/0009-0006-5796-024X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]},{"id":"https://openalex.org/I4405287106","display_name":"Institute of Natural Medicine, University of Toyama","ror":"https://ror.org/0449t5597","country_code":"JP","type":"facility","lineage":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Shinichiro Kato","raw_affiliation_strings":["Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Massachusetts","Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan","institution_ids":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078874539","display_name":"David E. Fisher","orcid":"https://orcid.org/0000-0002-5506-0575","observed_orcids":["https://orcid.org/0000-0002-5506-0575"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David E. Fisher","raw_affiliation_strings":["Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000395108","display_name":"Hiroaki Sakurai","orcid":"https://orcid.org/0000-0003-0657-9570","observed_orcids":["https://orcid.org/0000-0003-0657-9570"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Sakurai","raw_affiliation_strings":["Department of Cancer Cell Biology, Graduate School of Med-icine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan"],"raw_orcid":"https://orcid.org/0000-0003-0657-9570","affiliations":[{"raw_affiliation_string":"Department of Cancer Cell Biology, Graduate School of Med-icine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012119811","display_name":"Yoshihiro Hayakawa","orcid":"https://orcid.org/0000-0002-7921-1171","observed_orcids":["https://orcid.org/0000-0002-7921-1171"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]},{"id":"https://openalex.org/I4405287106","display_name":"Institute of Natural Medicine, University of Toyama","ror":"https://ror.org/0449t5597","country_code":"JP","type":"facility","lineage":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Hayakawa","raw_affiliation_strings":["Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan","institution_ids":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058893970","display_name":"Satoru Yokoyama","orcid":"https://orcid.org/0000-0001-8336-486X","observed_orcids":["https://orcid.org/0000-0001-8336-486X"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]},{"id":"https://openalex.org/I4405287106","display_name":"Institute of Natural Medicine, University of Toyama","ror":"https://ror.org/0449t5597","country_code":"JP","type":"facility","lineage":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Satoru Yokoyama","raw_affiliation_strings":["Department of Cancer Cell Biology, Graduate School of Med-icine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan","Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Cell Biology, Graduate School of Med-icine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Japan","institution_ids":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5058893970"],"corresponding_institution_ids":["https://openalex.org/I42766147","https://openalex.org/I4405287106"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9750000238418579},{"id":"https://openalex.org/keywords/dinaciclib","display_name":"dinaciclib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.8389999866485596},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":1.0},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.8159999847412109},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6647188663482666},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6253038048744202},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6010907888412476},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5870914459228516},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5860453844070435},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44383323192596436},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.4365343153476715},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37312179803848267},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33383631706237793},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28410714864730835},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.2378075122833252},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06496801972389221},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6538327.v1","doi":"https://doi.org/10.1158/1535-7163.c.6538327.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6538327.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6538327.v1","doi":"https://doi.org/10.1158/1535-7163.c.6538327.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6538327.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1552266425","https://openalex.org/W1851949377","https://openalex.org/W1868879889","https://openalex.org/W1965370740","https://openalex.org/W1966467063","https://openalex.org/W1970209296","https://openalex.org/W1971947883","https://openalex.org/W1972726145","https://openalex.org/W1982820305","https://openalex.org/W1982972087","https://openalex.org/W2016365699","https://openalex.org/W2038596114","https://openalex.org/W2047611018","https://openalex.org/W2052888848","https://openalex.org/W2053578467","https://openalex.org/W2055288483","https://openalex.org/W2074918415","https://openalex.org/W2080686146","https://openalex.org/W2081486992","https://openalex.org/W2081527131","https://openalex.org/W2088883749","https://openalex.org/W2097981550","https://openalex.org/W2106543129","https://openalex.org/W2128542677","https://openalex.org/W2137620209","https://openalex.org/W2140642045","https://openalex.org/W2141674733","https://openalex.org/W2144002245","https://openalex.org/W2145482514","https://openalex.org/W2153056550","https://openalex.org/W2157506582","https://openalex.org/W2158485828","https://openalex.org/W2170725518","https://openalex.org/W2298887797","https://openalex.org/W2343432753","https://openalex.org/W2493101410","https://openalex.org/W2504613444","https://openalex.org/W2617219619","https://openalex.org/W2759256200","https://openalex.org/W2781383440","https://openalex.org/W2887067858"],"related_works":["https://openalex.org/W2990321273","https://openalex.org/W1972726145","https://openalex.org/W2315134770","https://openalex.org/W140855618","https://openalex.org/W2497243288","https://openalex.org/W2774356865","https://openalex.org/W2319328441","https://openalex.org/W2783974691","https://openalex.org/W7144192544","https://openalex.org/W4361952544"],"abstract_inverted_index":{"Abstract":[0],"Mutation":[1],"of":[2,35,50,73,85,122],"the":[3,8,27,47,71,83],"oncogene":[4],"BRAF":[5,15,51,86],"is":[6],"among":[7],"most":[9,30],"common":[10],"genetic":[11],"alterations":[12],"in":[13,19,29,105,108],"melanoma.":[14],"inhibitors":[16,23,72,89],"alone":[17],"or":[18,37,146],"combination":[20,84,97],"with":[21,98],"MEK":[22,88],"fail":[24],"to":[25,33,45,69,116],"eradicate":[26],"tumor":[28],"patients":[31],"due":[32],"combinations":[34,135],"intrinsic":[36],"acquired":[38],"resistance.":[39],"Therefore,":[40],"novel":[41],"strategies":[42],"are":[43],"needed":[44],"improve":[46],"therapeutic":[48],"efficacy":[49],"inhibition.":[52],"We":[53],"demonstrated":[54],"that":[55],"dinaciclib":[56,99,115],"has":[57],"potent":[58],"antimelanoma":[59,94,124],"effects":[60],"by":[61,126,139],"inducing":[62],"BAK-dependent":[63],"apoptosis":[64,76],"through":[65,78],"MCL1":[66],"reduction.":[67],"Contrary":[68],"dinaciclib,":[70],"BRAF/MEK/CDK4/6":[74],"induced":[75],"dominantly":[77],"a":[79],"BAX-dependent":[80,123],"mechanism.":[81],"Although":[82],"and":[87,107,130],"did":[90],"not":[91],"exhibit":[92],"additive":[93],"effects,":[95],"their":[96],"synergistically":[100],"inhibited":[101],"melanoma":[102],"growth":[103],"both":[104],"vitro":[106],"vivo.":[109],"Collectively,":[110],"our":[111],"present":[112],"findings":[113],"suggest":[114],"be":[117,137],"an":[118],"effective":[119],"complementary":[120,141],"drug":[121,134],"drugs":[125,142],"targeting":[127],"BAK-mediated":[128],"apoptosis,":[129],"other":[131],"such":[132],"rational":[133],"can":[136],"determined":[138],"identifying":[140],"activating":[143],"either":[144],"BAK":[145],"BAX.":[147]},"counts_by_year":[],"updated_date":"2026-10-24T09:50:30.924529","created_date":"2023-04-05T00:00:00"}